Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PF614 for the Treatment of Moderate to Severe Pain After Abdominoplasty

NCT06602271 is registered in ClinicalTrials.gov with Ensysce Biosciences as lead sponsor.

NCT NCT06602271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06602271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PF614 for the Treatment of Moderate to Severe Pain After Abdominoplasty
Lead sponsor
Ensysce Biosciences
Phase
Phase 3
Overall status
Recruiting
Start date
December 9, 2025
Completion date
November 30, 2026
Enrollment
320 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative pain, acute